• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY UNKNOWN CATHETER; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY UNKNOWN CATHETER; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number UNKNOWN-C
Device Problems Inaccurate Flow Rate (1249); Occlusion Within Device (1423)
Patient Problem Therapeutic Response, Decreased (2271)
Event Type  Injury  
Manufacturer Narrative
This event was identified during review of scientific literature.The article contained only limited and non-specific device information.The event reported in the source literature could not be matched to information previously reported to medtronic neurosurgery.
 
Event Description
Joona tervonen, ville leinonen, juha e.Jaaskelainen, susanna koponen, terhi j.Huttunen.Rate and risk factors for shunt revision in pediatric patients with hydrocephalus-a population-based study.World neurosurgery 101 (2017).Doi: 10.1016/j.Wneu.2017.02.030 background: ventriculoperitoneal shunt (vps) is a common treatment for patients with hydrocephalus (hc).Vps is associated with complications that may lead to shunt revisions.We studied the surgical outcome of pediatric patients with hc in a population-based setting.Methods: the medical charts and imaging findings of 80 patients £16 years old who required vps secondary to hc were studied.Results: mean age at time of initial shunt placement was 3.2 years (sd 4.5) and mean follow-up time was 3.3 years (sd 2.9); 57% of patients were male.Half of patients underwent shunt revision with mean time to first revision of 8 months.Patients £6 months old had a higher shunt revision rate compared with patients >6 months old (p <(><<)> 0.001).The most common causes of hc requiring vps were tumors (27.5%), congenital defects (22.5%), and intraventricular hemorrhage (19%).Revision rates in the intraventricular hemorrhage and congenital defects groups were 67% (p [ 0.017) and 72% (p [ 0.016) compared with 32% in the tumor group.Programmable valves (56%) were more common than nonprogrammable valves, but there was no significant difference in shunt survival (p [ 0.632).The mean biparietal measurement change between preoperative and postoperative images was d0.9 mm in the no revision group and d6.6 mm in the revision group (p [ 0.003).Conclusions: half of patients with shunts required revision.Age £6 months and intraventricular hemorrhage and congenital defects etiologies of hc were associated with increased risk for shunt revision.Most revisions were done during the first year after the initial vps.Reported events: 7 patients required first revisions after primary shunt operation due to ventricular catheter obstruction and underdrainage.Two patients required first revisions after primary shunt operation due to peritioneal catheter obstruction and underdrainage.Four patients required first revisions after primary shunt operation due to ventricular catheter malposition and underdrainage.Two patients required first revisions after primary shunt operation due to peritioneal catheter malposition and underdrainage.See attached literature article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN CATHETER
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer Contact
stacy ruemping
7000 central avenue ne rcw215
minneapolis, MN 55432
7635260594
MDR Report Key6980952
MDR Text Key90396421
Report Number2021898-2017-00544
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeFI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN-C
Device Catalogue NumberUNKNOWN-C
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age2 YR
Patient Weight3
-
-